Delcath is a New York-based medical device company that develops and supplies percutaneous hepatic perfusion systems for the treatment of liver cancer.
Business Model:
Revenue: $4.2M
Employees: 51-200
Address: 1633 Broadway
City: New York
State: NY
Zip: 10019
Country: US
Delcath is a New York-based medical device company that develops and supplies percutaneous hepatic perfusion systems for the treatment of liver cancer.
Contact Phone:
+12124892100
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/10/2017
Ticker Symbol:
DCTH
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2022 | Post-IPO Equity | $3.8M | 6/2016 | Convertible Note | $35M | 12/2022 | Private Placement | $6.2M | 8/2021 | Post-IPO Debt | 1 | $20M |
Avenue Capital Group Avenue Capital Group |
8/2019 | Private Placement | $9.5M | 2/2018 | Post-IPO Equity | $5M | 12/2020 | Post-IPO Equity | $22.2M | 7/2019 | Post-IPO Equity | $20M | 4/2012 | Post-IPO Debt | 1 | $20M |
Silicon Valley Bank Silicon Valley Bank Silicon Valley Bank Silicon Valley Bank |
7/2022 | Post-IPO Equity | $5M | 7/2017 | Post-IPO Equity | $2M | 10/2007 | Post-IPO Equity | $14.2M | 12/2022 | Post-IPO Equity | $6.2M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|